FeRiva 21/7Rx OnlyDietary Supplement
FeRiva 21-7 28-Day by
Drug Labeling and Warnings
FeRiva 21-7 28-Day by is a Other medication manufactured, distributed, or labeled by Trifluent Pharma, LLC, Avion Pharmaceuticals, LLC. Drug facts, warnings, and ingredients follow.
Drug Details [pdf]
FERIVA 21-7 28-DAY- ascorbic acid, zinc glycinate, cyanocobalamin, ferrous asparto glycinate, folic acids and succinic acid tablet
Trifluent Pharma, LLC
----------
FeRiva 21/7
Rx Only
Dietary Supplement
DESCRIPTION
FeRiva 21/7® 28-Day tablets for oral administration is a 28-day iron supplement regimen that consists of 21 red, oval-shaped iron tablets and 7 purple, oval-shaped placebo tablets. Each red, oval-shaped iron tablet is debossed with “21” and “7” separated by a line in the middle on the top-side of the tablet and blank on the other side. Each purple, oval shaped placebo tablet is blank on both sides of the tablet.
| Supplement Facts
Serving Size: 1 tablet | % Daily Value | % Daily Value for Pregnant & Lactating Women |
|
|---|---|---|---|
| Each Red Iron Tablet Contains: | |||
| Vitamin C (as Ascorbic Acid) | 175 mg | 194% | 146% |
| Zinc (as Zinc Bisglycinate) | 10 mg | 91% | 77% |
| Vitamin B12 (as Cyanocobalamin) | 12 mcg | 500% | 429% |
| Iron (as Ferrrous Asparto Glycinate) Sumalate® | 75 mg | 417% | 278% |
|
Folate (as ((6S)-N5-methyltetrahydrofolic |
1,667 mcg DFW (from 600 mcg L-%-MTHF-Ca and 400 mcg folic acid) | 417% | 278% |
| Succinic Acid | 50 mg | † | † |
| † Daily Value (DV) not established. | |||
OTHER INGREDIENTS (RED IRON TABLETS)
Croscarmellose sodium, dicalcium phosphate, magnesium stearate, microcrystalline cellulose, silicon dioxide, and stearic acid. Coating contains: FD&C Red #40, HMPC, titanium dioxide and triacetin.
PURPLE PLACEBO TABLETS do not contain ANY vitamins, minerals, or other dietary ingredients. Please see OTHER INGREDIENTS section above for the listing of the inert ingredients.
INDICATIONS
FeRiva 21/7® 28-Day is a multivitamin/multimineral dietary supplement indicated for use in improving the nutritional status of patients with iron deficiency.
CONTRAINDICATIONS
FeRiva 21/7® 28-Day is contraindicated in patients with a known hyper-sensitivity to any of the ingredients. Hemochromatosis and hemosiderosis are contraindicated to iron therapy.
WARNING
Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.
PRECAUTIONS
Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where Vitamin B12 is deficient. Folic acid in doses above 1.0 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress. While prescribing this nutritional supplement for pregnant women, nursing mothers or for women prior to conception, their medical condition and other drugs, herbs and/or supplements consumption should be considered.
ADVERSE REACTIONS
Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
DOSAGE AND ADMINISTRATION
Usual dosage is one tablet daily with or without food or as prescribed by your healthcare provider.
The FeRiva 21/7® 28-Day tablets blister pack supplies a 28-day course of iron therapy that consists of 21 red iron tablets and 7 purple placebo tablets. Take 1 red iron tablet daily for 21 days, followed by 1 purple placebo tablet daily for 7 days. After 28 tablets have been taken a new course may be started if prescribed.
HOW SUPPLIED
FeRiva 21/7® 28-Day tablets blister pack (73352-318-28) contains of 21 red iron tablets and 7 purple placebo tablets. The listed product number is not a National Drug Code. Instead Trifluent Pharma has assigned a product code formatted according to standard industry practice to meet the formatting requirements of pharmacy and health insurance computer systems.
Keep out of reach of children. Store between 20°- 25°C (68°- 77°F).
Sumalate® is a registered trademark of Albion Laboratories, Inc., covered by one or more claims of U.S. Patent Nos. 6,716,814, 8,007,846, and 8,425,956.
Distributed By:
Trifluent Pharma, LLC
San Antonio, TX 78213
1-210-944-6920
Rev 01 04/25
| FERIVA 21-7 28-DAY
ascorbic acid, zinc glycinate, cyanocobalamin, ferrous asparto glycinate, folic acids and succinic acid tablet |
|||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||
| Supplement Facts | ||
| Serving Size : | Serving per Container : | |
| Amount Per Serving | % Daily Value | |
|---|---|---|
| color | ||
| color | ||
| scoring | 1 | |
| shape | ||
| size (solid drugs) | 7 mm | |
| imprint | ||
| Labeler - Trifluent Pharma, LLC (117167281) |
| Establishment | |||
| Name | Address | ID/FEI | Business Operations |
|---|---|---|---|
| Avion Pharmaceuticals, LLC | 040348516 | manufacture(73352-318) | |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.